D. Shapiro

发表

Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial.

P. Cahn, G. Siberry, E. Joao, 2020, The lancet. HIV.

Prevention of HIV-1 Transmission Through Breastfeeding: Efficacy and Safety of Maternal Antiretroviral Therapy Versus Infant Nevirapine Prophylaxis for Duration of Breastfeeding in HIV-1-Infected Women With High CD4 Cell Count (IMPAACT PROMISE) A Randomized, Open-Label, Clinical Trial

D. Moodley, L. Mofenson, G. Theron, 2017, Journal of acquired immune deficiency syndromes.

Mismatched double-stranded RNA, Ampligen (poly(I): poly(C12U), demonstrates antiviral and immunostimulatory activities in HIV disease.

D. Strayer, D. Gillespie, D. Shapiro, 1991, International journal of immunopharmacology.

Nonfasting Low-Density Lipoprotein Testing: Utility for Cholesterol Screening in Pediatric Primary Care

N. Rifai, E. Neufeld, S. D. de Ferranti, 2007, Clinical pediatrics.

Pharmacokinetics and Safety of Single-Dose Tenofovir Disoproxil Fumarate and Emtricitabine in HIV-1-Infected Pregnant Women and Their Infants

L. Mofenson, M. Purswani, D. H. Watts, 2011, Antimicrobial Agents and Chemotherapy.

Reduced indinavir exposure during pregnancy.

D. H. Watts, E. Capparelli, T. Cressey, 2013, British journal of clinical pharmacology.

Profile of Chronic Comorbid Conditions and Obstetrical Complications among Pregnant Women with HIV and Receiving Antiretroviral Therapy in the United States.

E. Livingston, J. Read, D. Shapiro, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Fosamprenavir with Ritonavir Pharmacokinetics during Pregnancy

E. Capparelli, E. Joao, S. Burchett, 2020, Antimicrobial Agents and Chemotherapy.

Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.

S. Gortmaker, E. Moore, L. Mofenson, 1999, JAMA.

Factors Associated With Lack of Viral Suppression at Delivery Among Highly Active Antiretroviral TherapyNaive Women With HIV

M. Hughes, I. Katz, E. Leister, 2015, Annals of Internal Medicine.

Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy.

E. Livingston, A. Bardeguez, K. Patel, 2010, The Journal of infectious diseases.

Prevalence of Congenital Anomalies in Infants With In Utero Exposure to Antiretrovirals

J. Read, H. Spiegel, D. Shapiro, 2012, The Pediatric infectious disease journal.

Resistance detected by pyrosequencing following zidovudine monotherapy for prevention of HIV-1 mother-to-child-transmission

Roger E Bumgarner, Ingrid A. Beck, J. Mullins, 2015, AIDS.

Maternal viral genotypic zidovudine resistance and infrequent failure of zidovudine therapy to prevent perinatal transmission of human immunodeficiency virus type 1 in pediatric AIDS Clinical Trials Group Protocol 076.

R. Sperling, R. Coombs, L. Frenkel, 1998, The Journal of infectious diseases.

Lack of tumors in infants with perinatal HIV-1 exposure and fetal/neonatal exposure to zidovudine.

L. Kalish, L. Mofenson, R. Sperling, 1999, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Effect of Cessation of Zidovudine Prophylaxis to Reduce Vertical Transmission on Maternal HIV Disease Progression and Survival

L. Mofenson, R. Sperling, M. Fowler, 2003, Journal of acquired immune deficiency syndromes.

Safety of the maternal–infant zidovudine regimen utilized in the Pediatric AIDS Clinical Trial Group 076 Study

R. Sperling, R. Coombs, J. Delfraissy, 1998, AIDS.

Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention.

B. Chi, D. Moodley, L. Mofenson, 2016, The New England journal of medicine.

Pharmacokinetics and Safety of Single-Dose Tenofovir Disoproxil Fumarate and Emtricitabine in HIV-1-Infected Pregnant Women and Their Infants (cid:1)

L. Mofenson, M. Purswani, D. H. Watts, 2011 .

Absolute Copy Number and Relative Change in Determinations of Human Immunodeficiency Virus Type 1 RNA in Plasma: Effect of an External Standard on Kit Comparisons

R. Sperling, J. Bremer, P. Reichelderfer, 1998, Journal of Clinical Microbiology.

Maternal and infant renal safety following tenofovir disoproxil fumarate exposure during pregnancy in a randomized control trial

B. Chi, D. Moodley, G. Theron, 2022, BMC Infectious Diseases.

Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa

Michael I. Jordan, Donald A. Jackson, J. G. Ndirangu, 2016, Journal of the International AIDS Society.

Assessment of minority frequency pretreatment HIV drug-resistant variants in pregnant women and associations with virologic non-suppression at term

Ingrid A. Beck, E. Joao, M. Mirochnick, 2022, PloS one.

Infant Outcomes After Maternal Antiretroviral Exposure in Resource-Limited Settings

L. Mofenson, J. Currier, J. Hitti, 2012, Pediatrics.

The effects of zidovudine in the subset of infants infected with human immunodeficiency virus type-1 (Pediatric AIDS Clinical Trials Group Protocol 076).

N. McGrath, R. Sperling, R. Coombs, 1999, The Journal of pediatrics.

Darunavir pharmacokinetics with an increased dose during pregnancy.

E. Capparelli, M. Mirochnick, N. Chakhtoura, 2020, Journal of acquired immune deficiency syndromes.

Birth Outcomes for Pregnant Women with HIV Using Tenofovir–Emtricitabine

Paige L. Williams, S. Hernández-Díaz, E. Barr, 2018, The New England journal of medicine.

Rapid Onset of Cutaneous Anesthesia with EMLA Cream After Pretreatment with a New Ultrasound-Emitting Device

J. Kost, Nathaniel Katz, D. Shapiro, 2004, Anesthesia and analgesia.

Nucleoside exposure in the children of HIV-infected women receiving antiretroviral drugs: Absence of clear evidence for mitochondrial disease in children who died before 5 years of age in five United States cohorts

L. Mofenson, M. Lindegren, M. Fowler, 2000 .

Lack of increased hepatotoxicity in HIV-infected pregnant women receiving nevirapine compared with other antiretrovirals

R. Leighty, R. Hershow, A. French, 2010, AIDS.

Effects of Initiating Raltegravir-Based Versus Efavirenz-Based Antiretroviral Regimens During Pregnancy on Weight Changes and Perinatal Outcomes: NICHD P1081

E. Joao, G. Duarte, A. Violari, 2022, Journal of acquired immune deficiency syndromes.

Efavirenz Pharmacokinetics during Pregnancy and Infant Washout

T. Cressey, M. Mirochnick, B. Best, 2019, Antiviral therapy.

Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

J L Sullivan, R. Gelber, S. Spector, 1996, The New England journal of medicine.

Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies/ml.

J. Goedert, J. Ioannidis, B. Korber, 2001, The Journal of infectious diseases.

Maternal viral load and rate of disease progression among vertically HIV-1-infected children: an international meta-analysis

Athina Tatsioni, Marie-Louise Newell, Bruce Thompson, 2003, AIDS.

A comparison of 3 regimens to prevent nevirapine resistance mutations in HIV-infected pregnant women receiving a single intrapartum dose of nevirapine.

Ingrid A. Beck, T. Puthanakit, L. Frenkel, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Pharmacokinetics of tenofovir alafenamide with and without cobicistat in pregnant and postpartum women living with HIV: Results from IMPAACT P1026s.

R. Haubrich, E. Barr, E. Capparelli, 2020, AIDS.

Pharmacokinetics and safety of stavudine in HIV-infected pregnant women and their infants: Pediatric AIDS Clinical Trials Group protocol 332.

L. Mofenson, J. Hitti, J. Unadkat, 2004, The Journal of infectious diseases.

Early Postpartum Pharmacokinetics of Lopinavir Initiated Intrapartum in Thai Women

T. Puthanakit, T. Cressey, M. Mirochnick, 2009, Antimicrobial Agents and Chemotherapy.

Interactions Between Etonogestrel-Releasing Contraceptive Implant and Three Antiretroviral Regimens.

E. Capparelli, M. Mirochnick, N. Chakhtoura, 2021, Contraception.

Pharmacokinetics of Rilpivirine in HIV-Infected Pregnant Women

E. Capparelli, S. Burchett, T. Cressey, 2016, Journal of acquired immune deficiency syndromes.

Pharmacokinetics of Tenofovir Alafenamide With Boosted Protease Inhibitors in Pregnant and Postpartum Women Living With HIV: Results From IMPAACT P1026s

E. Barr, E. Capparelli, M. Paul, 2022, Journal of acquired immune deficiency syndromes.

Pharmacokinetics of Once Versus Twice Daily Darunavir in Pregnant HIV-Infected Women

L. Mofenson, E. Capparelli, S. Burchett, 2015, Journal of acquired immune deficiency syndromes.

Elvitegravir/cobicistat pharmacokinetics in pregnant and postpartum women with HIV

E. Barr, E. Acosta, M. Purswani, 2018, AIDS.

Raltegravir Pharmacokinetics During Pregnancy

F. Aweeka, D. H. Watts, E. Capparelli, 2014, Journal of acquired immune deficiency syndromes.

Antiretroviral therapy during pregnancy and the risk of an adverse outcome.

M. Hughes, L. Mofenson, D. Wara, 2002, The New England journal of medicine.

A comparison of the bioavailabilities of oral and intravenous ethanol in healthy male volunteers.

D. J. Cobaugh, D. Shapiro, S. Schneider, 1999, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

The contribution of assay variation and biological variation to the total variability of plasma HIV-1 RNA measurements. The Women Infant Transmission Study Clinics. Virology Quality Assurance Program.

S. Hammer, D. Katzenstein, A. Collier, 1999, AIDS.

Birth Weight and Preterm Delivery Outcomes of Perinatally vs Nonperinatally Human Immunodeficiency Virus-Infected Pregnant Women in the United States: Results From the PHACS SMARTT Study and IMPAACT P1025 Protocol

M. McNichols, S. Bewley, W. Borkowsky, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Biomarkers From Late Pregnancy to 6 Weeks Postpartum in HIV-Infected Women Who Continue Versus Discontinue Antiretroviral Therapy After Delivery

J. Currier, E. Leister, Y. Bryson, 2013, Journal of acquired immune deficiency syndromes.

Maternal health outcomes among HIV-infected breastfeeding women with high CD4 counts: results of a treatment strategy trial

B. Chi, D. Moodley, G. Theron, 2018, HIV clinical trials.

Pharmacokinetics of an Increased Atazanavir Dose With and Without Tenofovir During the Third Trimester of Pregnancy

D. H. Watts, S. Burchett, T. Cressey, 2013, Journal of acquired immune deficiency syndromes.

Changing Patterns and Factors Associated With Mode of Delivery Among Pregnant Women With Human Immunodeficiency Virus Infection in the United States.

E. Livingston, J. Read, D. Shapiro, 2018, Obstetrics and gynecology.

Pharmacokinetics of Increased Nelfinavir Plasma Concentrations in Women During Pregnancy and Postpartum

L. Mofenson, E. Capparelli, M. Mirochnick, 2018, Journal of clinical pharmacology.

Enrollment and transition challenges in the International Maternal Pediatric and Adolescent AIDS Clinical Trials (IMPAACT) network’s PROMISE trial for resource-limited regions

M. Fowler, J. McIntyre, S. Brummel, 2020, Clinical trials.

Randomized trial of stopping or continuing ART among postpartum women with pre-ART CD4 ≥ 400 cells/mm3

L. Mofenson, L. Aurpibul, J. Currier, 2017, PloS one.

Analysis of the maternal components of the AIDS clinical trial group 076 zidovudine regimen in the prevention of mother-to-infant transmission of human immunodeficiency virus type 1.

M. Cowles, D. H. Watts, L. Frenkel, 1997, The Journal of infectious diseases.

Prevalence of HIV among women entering labor who accepted or declined voluntary counseling and testing

G. Theron, D. Shapiro, M. Bulterys, 2013, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Association of Maternal Viral Load and CD4 Count With Perinatal HIV-1 Transmission Risk During Breastfeeding in the PROMISE Postpartum Component

Ingrid A. Beck, D. Moodley, L. Mofenson, 2021, Journal of acquired immune deficiency syndromes.

Brief Report: Vaginal Viral Shedding With Undetectable Plasma HIV Viral Load in Pregnant Women Receiving 2 Different Antiretroviral Regimens: A Randomized Clinical Trial

E. Joao, R. Coombs, L. Frenkel, 2021, Journal of acquired immune deficiency syndromes.

A controlled clinical trial with a specifically configured RNA drug, poly(I).poly(C12U), in chronic fatigue syndrome.

M. Loveless, D. Strayer, I. Brodsky, 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Pharmacokinetics of darunavir and cobicistat in pregnant and postpartum women with HIV.

E. Capparelli, M. Paul, S. Burchett, 2021, AIDS.

The frequency of selective IgA deficiency in myasthenia gravis

R. Liblau, D. Shapiro, J. Bach, 1992, Neurology.

Self-reported Antiretroviral Adherence: Association With Maternal Viral Load Suppression in Postpartum Women Living With HIV-1 From Promoting Maternal and Infant Survival Everywhere, a Randomized Controlled Trial in Sub-Saharan Africa and India

D. Moodley, J. Currier, M. Fowler, 2022, Journal of acquired immune deficiency syndromes.

Site-Randomized Controlled Trial of a Combined Cognitive Behavioral Therapy and a Medication Management Algorithm for Treatment of Depression Among Youth Living With HIV in the United States

S. Spector, M. Purswani, L. Brown, 2021, Journal of acquired immune deficiency syndromes.

Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant

C. Rouzioux, R. Sperling, R. Coombs, 1997 .

Mother to Child Human Immunodeficiency Virus Transmission Trials

D. Shapiro, 2014 .

Prevalence of neurotoxicity symptoms among postpartum women on isoniazid preventive therapy and efavirenz-based treatment for HIV: an exploratory objective of the IMPAACT P1078 randomized trial

G. Montepiedra, L. Mokgatlhe, W. El-Sadr, 2023, BMC Pregnancy and Childbirth.

Increased risk of hepatotoxicity in HIV-infected pregnant women receiving antiretroviral therapy independent of nevirapine exposure

R. Leighty, R. Hershow, A. French, 2009, AIDS.

Factors Associated With Lack of Viral Suppression at Delivery

I. Katz, D. Shapiro, R. Tuomala, 2015, Annals of Internal Medicine.

Stereotypes about Americans and Europeans Who Make Specific Statements

H. Perlmutter, D. Shapiro, 1957 .

Potential confounding of the association between exposure to nucleoside analogues and mitochondrial dysfunction in HIV-uninfected and indeterminate infants.

L. Mofenson, E. Cooper, R. Viani, 2010, Journal of acquired immune deficiency syndromes.

Forty-Eight Week Outcomes of a Site-Randomized Trial of Combined Cognitive Behavioral Therapy and Medication Management Algorithm for Treatment of Depression Among Youth With HIV in the United States

L. Brown, L. Whiteley, M. Chernoff, 2022, Journal of acquired immune deficiency syndromes.

Effect of zidovudine on perinatal HIV-1 transmission and maternal viral load

R. Sperling, R. Coombs, D. Shapiro, 1999, The Lancet.

Time to first positive HIV-1 DNA PCR may differ with antiretroviral regimen in infants infected with non-B subtype HIV-1

M. Hughes, S. Lockman, M. Fowler, 2017, AIDS.

Stratified Weibull Regression Model for Interval-Censored Data

M. Hughes, R. Balasubramanian, D. Shapiro, 2014, R J..

Pharmacokinetics of Atazanavir Boosted With Cobicistat in Pregnant and Postpartum Women With HIV

E. Capparelli, M. Paul, J. Momper, 2021, Journal of acquired immune deficiency syndromes.

Risk factors for perinatal human immunodeficiency virus transmission in patients receiving zidovudine prophylaxis. Pediatric AIDS Clinical Trials Group protocol 076 Study Group.

D. Shapiro, R. Sperling, L. Mandelbrot, 1999, Obstetrics and gynecology.

Birth Outcomes for Pregnant Women With HIV Using Tenofovir-Emtricitabine

S. Hernández-Díaz, E. Barr, J. Currier, 2018, Obstetrical & Gynecological Survey.

Pharmacokinetics of Rilpivirine in HIV-Infected Pregnant Women

E. Capparelli, S. Burchett, T. Cressey, 2016, Journal of acquired immune deficiency syndromes.